
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
Keywords: ایمونوتراپی; Glioma; Immunotherapy; Vaccine; Allogeneic; Autologous;